Author Archives: alainamstutz

Delinkage Paradigm

1) See how Michelle Childs (former head of policy and advocacy at MSF’s access campaign) explains delinkage: 2) See how Katy Athersuch (medical innovation & access policy adviser for the MSF access campaign) explains delinkage and the recent process at WHO to promote new innovative proposals for our current R&D framework. Disappointingly the much […]

Flaws of the current R&D system

Thanks to medical research many lifesaving medicines, useful therapies and devices have been developed over the last decades. However, our current research & development (R&D) framework has some major flaws and raises huge access and innovation problems, because its main incentive is based on legal marketing monopolies, enforced through patents (at least 20 years): –       […]